https://updates.biomednexus.com/ 2025-12-09 https://updates.biomednexus.com/archive 2025-12-15 https://updates.biomednexus.com/authors 2025-12-09 https://updates.biomednexus.com/catalysts 2025-12-15 https://updates.biomednexus.com/jpm-2026 2026-01-13 https://updates.biomednexus.com/pro-hub 2026-01-13 https://updates.biomednexus.com/subscribe 2025-12-09 https://updates.biomednexus.com/upgrade 2026-01-16 https://updates.biomednexus.com/authors/biomed-nexus 2025-12-02 https://updates.biomednexus.com/forms/e15e6887-9656-458d-a35a-57145a695399 2025-10-23 https://updates.biomednexus.com/forms/734e8731-66f3-4a28-97f0-f1f8814ca67f 2025-03-09 https://updates.biomednexus.com/p/gilead-pays-79-premium-for-arcellx-fda-drafts-plausible-mechanism-pathway-vir-1-7b-deal 2026-02-24 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-79-2025 2025-11-27 https://updates.biomednexus.com/p/gsk-s-950m-pah-bet-35pharma-deal-signals-activin-race 2026-02-26 https://updates.biomednexus.com/p/roche-kidney-breakthrough-sanofi-s-2-4b-ocular-gamble-medtronic-earnings 2026-02-17 https://updates.biomednexus.com/p/prime-tests-two-patient-fda-approval-moderna-s-2-25b-patent-deal-glenmark-flovent-win 2026-03-05 https://updates.biomednexus.com/p/biomed-nexus-jpm-week-opens-capital-signals-in-focus 2026-01-12 https://updates.biomednexus.com/p/lilly-flags-glp-1-impurity-hims-exits-compounding-sana-durability 2026-03-16 https://updates.biomednexus.com/p/markets-reopen-the-2-5b-supply-test-and-the-j-j-setup 2026-01-21 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-14-2025-updated 2025-11-27 https://updates.biomednexus.com/p/the-week-ahead-jnj-abbott-the-post-jpm-pivot 2026-01-19 https://updates.biomednexus.com/p/fda-sets-trial-free-precedent-for-ultra-rare-disease-biontech-founders-pivot-hims-lands-ozempic 2026-03-11 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-6-2025 2025-11-06 https://updates.biomednexus.com/p/weekly-recap-fda-rejects-moderna-disc-bridgebio-phase-3-win-hrt-label-shift 2026-02-16 https://updates.biomednexus.com/p/priovant-phase-2-breakthrough-regenxbio-pdufa-watch-eikon-ipo-down-19 2026-02-09 https://updates.biomednexus.com/p/novo-launches-wegovy-subscriptions-cuts-400-manufacturing-jobs-and-medtronic-expands-its-surgical-ro 2026-04-02 BioMed Nexus en 2026-04-02T09:00:00Z Novo Launches Wegovy Subscriptions, Cuts 400 Manufacturing Jobs, and Medtronic Expands Its Surgical Robot https://updates.biomednexus.com/p/innoviva-approved-aldeyra-s-final-verdict 2025-12-15 https://updates.biomednexus.com/p/teva-lands-400m-blackstone-deal-j-j-s-fifth-fast-track-ucb-s-1-1b-cd19-bet 2026-03-04 https://updates.biomednexus.com/p/alumis-soars-95-amgen-buys-dark-blue-up-to-840m-lilly-re-ups 2026-01-07 https://updates.biomednexus.com/p/pfizer-s-lyme-vaccine-misses-but-files-anyway-apogee-s-twice-a-year-eczema-shot 2026-03-24 https://updates.biomednexus.com/p/deal-rush-scineuro-s-53m-win-the-ash-2025-preview 2025-12-05 https://updates.biomednexus.com/p/signing-off-the-2025-finale-holiday-risk-list 2025-12-23 https://updates.biomednexus.com/p/fda-precheck-pilot-opens-sanofi-split-in-gaucher-and-fabry 2026-02-03 https://updates.biomednexus.com/p/fda-signals-shift-to-single-trial-standard-insmed-guides-to-1b-madrigal-nears-blockbuster 2026-02-20 https://updates.biomednexus.com/p/13-4b-in-m-a-drops-in-a-single-day-lilly-enters-sleep-medicine 2026-04-01 https://updates.biomednexus.com/p/japan-approves-first-ips-therapies-xenon-s-record-epilepsy-data-fda-eases-biosimilar-path 2026-03-10 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-13-2025 2025-11-27 https://updates.biomednexus.com/p/enhertu-approved-aldeyra-delayed-roche-wins 2025-12-16 https://updates.biomednexus.com/p/ocular-superiority-vs-25-drop-danaher-buys-masimo-medtronic-pfa-surge 2026-02-18 https://updates.biomednexus.com/p/jpm-day-2-novo-lilly-obesity-day-1-recap 2026-01-13 https://updates.biomednexus.com/p/obesity-shock-wave-147-structure-102-redefine-the-market 2025-12-09 https://updates.biomednexus.com/p/clinical-wins-meet-operational-reality 2026-01-15 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-19-2025 2025-11-27 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-26-2025 2025-11-27 https://updates.biomednexus.com/p/the-divergence-why-kodiak-soared-12-vs-immunome-sank 2025-12-18 https://updates.biomednexus.com/p/week-in-review-yuviwel-approved-generate-s-rough-debut-44-day-precedent 2026-03-02 https://updates.biomednexus.com/p/chart-of-the-week-the-obesity-gap-pfizer-s-new-2b-bet 2025-12-10 https://updates.biomednexus.com/p/2026-kickoff-the-holiday-winners-losers 2026-01-05 https://updates.biomednexus.com/p/first-gene-therapy-for-lad-i-approved-acc-26-reshapes-cardiology 2026-03-30 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-4-2025 2025-11-04 https://updates.biomednexus.com/p/0-pharma-tariffs-exact-s-21b-exit-and-fda-s-vaccine-shift-biomed-nexus-daily 2025-12-02 https://updates.biomednexus.com/p/biosecure-passes-adc-scare-athira-73 2025-12-19 https://updates.biomednexus.com/p/capital-reprices-the-stack-257m-bet 2026-01-29 https://updates.biomednexus.com/p/merck-pays-6-7b-to-secure-its-post-keytruda-future 2026-03-26 https://updates.biomednexus.com/p/rhythm-wins-ho-approval-lilly-s-triple-agonist-crushes-ph3-the-glp-1-arms-race 2026-03-20 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-17-2025 2025-11-27 https://updates.biomednexus.com/p/lilly-s-compounding-crackdown-ultragenyx-hits-ph3-novo-s-asset-slide 2026-03-13 https://updates.biomednexus.com/p/bicycle-just-shelved-its-padcev-challenger-the-fda-killed-reproxalap-for-a-third-time-and-jensen-hua 2026-03-18 https://updates.biomednexus.com/p/pdufa-watch-biocryst-amgen-decisions-post-cpi-rally 2025-12-11 https://updates.biomednexus.com/p/2-2b-reenters-biotech-lilly-leads-the-charge 2026-01-09 https://updates.biomednexus.com/p/moderna-flu-rtf-regenxbio-crl-fda-bha-review 2026-02-11 https://updates.biomednexus.com/p/fda-s-44-day-approval-sarepta-ceo-exits-biomarin-pulls-roctavian 2026-02-27 https://updates.biomednexus.com/p/capital-gets-conditional-unh-sets-the-2026-baseline 2026-01-27 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-14-2025 2025-11-14 https://updates.biomednexus.com/p/the-jpm-2026-planner-the-shadow-week-playbook 2026-01-05 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-23-2025 2025-11-27 https://updates.biomednexus.com/p/3b-in-t-cell-engager-deals-drop-in-one-day-gilead-and-sanofi-bet-big 2026-03-25 https://updates.biomednexus.com/p/celcuity-secures-priority-review-cro-consolidation-accelerates 2026-01-21 https://updates.biomednexus.com/p/hhs-pivots-100m-to-antivirals-pfizer-obesity-miss-4 2026-02-04 https://updates.biomednexus.com/p/fda-reverses-moderna-rtf-j-j-onshores-cell-therapy 2026-02-19 https://updates.biomednexus.com/p/intrabio-s-rare-disease-win-fda-s-new-myeloma-standard 2026-01-22 https://updates.biomednexus.com/p/four-fda-approvals-in-one-week-novartis-drops-3b-the-obesity-war-just-got-a-new-front 2026-03-23 https://updates.biomednexus.com/p/bridgebio-s-lgmd-breakthrough-stryker-cyberattack-vima-adds-40m 2026-03-12 https://updates.biomednexus.com/p/abbott-s-libre-safety-shock-itvisma-s-gene-therapy-expansion 2025-11-27 https://updates.biomednexus.com/p/fda-approves-bysanti-the-single-trial-era-begins 2026-02-23 https://updates.biomednexus.com/p/novo-cuts-glp-1-prices-50-ahead-of-federal-pricing-push 2026-02-25 https://updates.biomednexus.com/p/fda-splits-gene-therapy-uniqure-rejected-intellia-hold-lifted 2026-03-03 https://updates.biomednexus.com/p/lilly-s-2-75b-ai-deal-resets-drug-discovery 2026-03-31 https://updates.biomednexus.com/p/fda-clean-label-enforcement-shift-trumprx-platform-launch 2026-02-06 https://updates.biomednexus.com/p/bridgebio-phase-3-win-fda-hrt-label-shift-universal-flu-trial 2026-02-13 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-5-2025 2025-11-05 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-7-2025 2025-11-07 https://updates.biomednexus.com/p/google-enters-the-clinic-biocryst-decision-day 2025-12-12 https://updates.biomednexus.com/p/novo-launches-wegovy-subscriptions-cuts-400-manufacturing-jobs-and-medtronic-expands-its-surgical-ro-2f89 2026-04-03 BioMed Nexus en 2026-04-03T09:00:00Z Q1 Ends with $46.8B in M&A and a 7% XBI Surge • Immunovant TED Trial Misses https://updates.biomednexus.com/p/servier-buys-day-one-for-2-5b-cber-chief-prasad-to-exit-lonza-s-3b-cdmo-pivot 2026-03-09 https://updates.biomednexus.com/p/sarepta-s-sirna-breakout-35 2026-03-27 https://updates.biomednexus.com/p/fda-shock-pazdur-out-the-150m-gene-writing-bet 2025-12-03 https://updates.biomednexus.com/p/the-repricing-of-managed-care-unh-20-on-rate-shock-intellia-lift 2026-01-28 https://updates.biomednexus.com/p/the-500-gainer-capricor-s-win-medtronic-s-robot-war 2025-12-04 https://updates.biomednexus.com/p/obesity-s-volume-vs-value-moment 2026-01-14 https://updates.biomednexus.com/p/j-j-cracks-the-oral-il-23-code-gossamer-cuts-48-rhythm-s-moment-is-tomorrow 2026-03-19 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-20-2025 2025-11-27 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-25-2025 2025-11-27 https://updates.biomednexus.com/p/gsk-wins-aldeyra-delays-xoma-s-zombie-play 2025-12-17 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-12-2025 2025-11-27 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-11-2025 2025-11-27 https://updates.biomednexus.com/p/telehealth-reverts-astrazeneca-s-18-5b-metabolic-alliance 2026-02-02 https://updates.biomednexus.com/p/liquidity-returns-alumis-secures-300m-runway-asco-gi-preview 2026-01-08 https://updates.biomednexus.com/p/jpm-2026-sanofi-buys-dynavax-2-2b-zenas-ph3-win-data-correction 2026-01-06 https://updates.biomednexus.com/p/jpm-wrap-up-when-hype-gave-way-to-reality 2026-01-16 https://updates.biomednexus.com/p/lilly-innovent-partnership-takeda-s-ai-strategy-j-j-recall 2026-02-10 https://updates.biomednexus.com/p/ai-pivot-in-biotech-grail-fda-move-500m-deal 2026-01-30 https://updates.biomednexus.com/p/pharma-s-gpu-arms-race-accelerates-roche-vs-lilly-at-gtc 2026-03-17 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-18-2025 2025-11-27 https://updates.biomednexus.com/p/monday-brief-capital-gets-conditional 2026-01-26 https://updates.biomednexus.com/p/the-ipo-window-reopens-eikon-s-381m-debut-oncology-pipeline-updates 2026-02-05 https://updates.biomednexus.com/p/bms-bets-850m-on-janux-corxel-s-massive-series-d 2026-01-23 https://updates.biomednexus.com/p/global-car-t-approval-505-b-2-oncology-deal-and-biomimetics-surge 2025-11-28 https://updates.biomednexus.com/p/diagnostics-pivot-gene-therapy-expansion-cgm-safety-shock 2025-12-01 https://updates.biomednexus.com/p/biomed-nexus-daily-newsletter-november-21-2025 2025-11-27 https://updates.biomednexus.com/p/merck-keytruda-win-madrigal-4-4b-deal-jobs-report-surprise 2026-02-12 https://updates.biomednexus.com/p/j-j-s-55-day-fda-approval-cvs-google-launch-ai-health-platform-trumprx-stalls 2026-03-06 https://updates.biomednexus.com/p/ash-shock-vertex-arcellx-win-the-oral-glp-1-verdict-today 2025-12-09